Sanctuary Advisors’s Tourmaline Bio TRML Stock Holding History

Sanctuary Advisors’s Portfolio TRML Stock Details TRML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-7,633	Closed	-$365K	–	2572
2025 Q3	$365K	Buy	+7,633	New	+$212K	﹤0.01%	1885

Sanctuary Advisors's TRML Position: Q4 2025 in Review

Sanctuary Advisors sold out of Tourmaline Bio (TRML) in Q4 2025, closing a stake of 7,633 shares — an estimated $365K sold.

Sanctuary Advisors first reported a position in TRML in Q3 2025 and held it in 1 quarter. The position peaked at $365K in Q3 2025. 0 funds tracked by Wall St. Rank hold TRML as of Q4 2025.

Sanctuary Advisors reported no remaining Tourmaline Bio position as of Q4 2025 after selling out during the quarter.
Sanctuary Advisors sold 7,633 Tourmaline Bio shares in Q4 2025, an estimated $365K.
Sanctuary Advisors first reported a position in Tourmaline Bio in Q3 2025 and held it in 1 quarter.
Sanctuary Advisors's Tourmaline Bio position peaked at $365K in Q3 2025.
0 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2025.

Based on Sanctuary Advisors's 13F filing for Q4 2025, filed 29 Jan 2026.